During this presentation, we welcome Shuttle Pharmaceuticals. Shuttle is traded on the Nasdaq under the symbol SHPH. And joining us today from the company is Dr. Anatoly Dritschilo, the company’s Chairman and CEO.

Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT).

This Company Webcast was recorded during the Lytham Partners Spring 2024 Investor Conference.